GEN Exclusives

More »

GEN News Highlights

More »
Aug 31, 2009

Novartis to Exploit Nuevolution Platform for Drug Discovery

  • Novartis enlisted the help of Danish drug discovery company Nuevolution to identify small molecule leads against specific drug targets. Nuevolution will use its fragment-based drug screening platform called Chemetics®. The company says this technology combines proven wet chemistry and molecular biology to allow the rapid synthesis and selection of ligands from potentially billions of drug-like compounds in a single test tube.  The companies will work together to carry out hit-to-lead optimization.


Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Genetics and Intelligence

Do you believe research on the genetics of intelligence can improve education?

More »